Cardiovascular Safety and Efficacy of the PCSK9 Inhibitor Evolocumab in Diabetes and the Risk of Development of Diabetes: A Prespecified Analysis from the Randomized Controlled FOURIER Trial
Articolo
Data di Pubblicazione:
2017
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Sabatine, Ms; Leiter, La; Wiviott, Sd; Giugliano, Rp; Deedwania, P; DE FERRARI, Gaetano; Murphy, Sa; Kuder, Jf; Gouni-Berthold, J; Lewis, Bs; Handelsman, Y; Lira Pineda, A; Honarpour, N; Keech, Ac; Sever, Ps; Pedersen, Tr
Link alla scheda completa:
Pubblicato in: